Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Nutraacne (also marketed as Nutracne Fem) is an oral nutraceutical supplement developed by Brinton Pharmaceuticals in technical collaboration with Vitane Pharmaceuticals. Formulated as a tablet, it is designed to provide nutritional support for maintaining clear skin and managing acne, particularly hormonal acne in women. The supplement contains a synergistic blend of active ingredients, including N-acetyl cysteine (NAC), alpha lipoic acid, inositol, niacinamide, zinc gluconate, D-panthenol, chromium picolinate, and vitamin A acetate. These components work together to provide antioxidant support, regulate hormonal balance (by improving insulin sensitivity and modulating androgen levels), reduce skin inflammation, and support skin repair and regeneration.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Nutraacne.